18.6 Million Cancer Survivors in the United States as of Jan. 1, 2025

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 30, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 30, 2025 -- The number of cancer survivors in the United States reached 18.6 million as of Jan. 1, 2025, and is projected to exceed 22 million by 2035, according to a study published online May 30 in CA: A Cancer Journal for Clinicians.

Nikita Sandeep Wagle, Ph.D., M.B.B.S., from the American Cancer Society in Atlanta, and colleagues estimated cancer prevalence in the United States using data from national registries.

The authors note that as of Jan. 1, 2025, there were over 18.6 million people living in the United States with a history of cancer; by 2035, this number is projected to reach more than 22 million. Prostate, melanoma of the skin, and colorectum cancer are the most prevalent among males, while breast, uterine corpus, and thyroid cancer are the most prevalent among females.

Fifty-one percent of survivors were diagnosed within the past 10 years; 79 percent were 60 years and older. In 2021, racial differences in treatment were common across disease stage; for example, among those with stage I to II lung cancer, Black patients were less likely than White patients to undergo surgery (47 versus 52 percent). For rectal cancer, larger disparities were seen, with 39 and 64 percent of Black and White people, respectively, with stage I disease undergoing proctectomy or proctocolectomy.

"Survivorship experiences and outcomes are not equitable across populations," the authors write. "Access to treatment and supportive care differs across racial and ethnic groups, influencing cancer‐related outcomes. These differences are influenced by longstanding societal and health care system factors."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-31 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords